van Cooten Véronique V, van Hamont Dennis, Siebers Albert G, Alcalá Luthy, Bekkers Ruud L M, Speksnijder Leonie
Department of Obstetrics and Gynaecology, Division of Urogynecology, Amphia Hospital, Breda, The Netherlands.
GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Arch Gynecol Obstet. 2025 Oct;312(4):1287-1294. doi: 10.1007/s00404-025-08135-y. Epub 2025 Jul 24.
To examine the safety of omitting routine histopathological examination by determining the prevalence of cervical pathology in women after cervical amputation as part of pelvic organ prolapse (POP) surgery without pre-existing indication for histology and the necessity of additional treatment.
A cross-sectional study was performed using data of women who underwent cervical amputation as part of POP without pre-existing indication for histopathological examination, obtained from Palga, the Dutch nationwide pathology databank, between January 1991 and January 2022.
The prevalences of the following histological diagnoses were determined: Cervical Intraepithelial Neoplasia (CIN I-III), adenocarcinomas in situ (AIS), cervical carcinomas, and other malignancies.
In total, 14.887 patients were included in this study, with a median age of 61.4 years (SD = 11.7). The prevalence of CIN II+ lesions was 6.9 [95%-CI 5.6, 8.3] per 1000 women, while one cervical carcinoma (6.7 [95%-CI -0.6, 19.9] per 100.000 women) was reported (stage IA1 microinvasive squamous cell carcinoma).
This study found a prevalence of 0.7% for CIN II+ incidental findings in women undergoing amputation of the cervix as part of POP surgery. No additional treatments were required after the final histopathological results. The decision to omit routine histopathological examination could potentially be safe, offering the prospect of reduced healthcare costs and environmental impact. Healthcare professionals should individually assess the risks and benefits of omitting and/or replacing routine histopathological examination.
通过确定作为盆腔器官脱垂(POP)手术一部分进行宫颈切除术后女性宫颈病变的患病率以及额外治疗的必要性,来研究省略常规组织病理学检查的安全性。
进行了一项横断面研究,使用1991年1月至2022年1月期间从荷兰全国病理学数据库Palga获得的、作为POP手术一部分进行宫颈切除且无组织病理学检查预先指征的女性数据。
确定以下组织学诊断的患病率:宫颈上皮内瘤变(CIN I-III)、原位腺癌(AIS)、宫颈癌和其他恶性肿瘤。
本研究共纳入14887例患者,中位年龄为61.4岁(标准差=11.7)。CIN II+病变的患病率为每1000名女性6.9例[95%置信区间5.6,8.3],报告了1例宫颈癌(每100000名女性6.7例[95%置信区间-0.6,19.9])(IA1期微浸润性鳞状细胞癌)。
本研究发现,作为POP手术一部分进行宫颈切除术的女性中,CIN II+偶然发现的患病率为0.7%。最终组织病理学结果出来后无需额外治疗。省略常规组织病理学检查的决定可能是安全的,有望降低医疗成本和环境影响。医疗保健专业人员应单独评估省略和/或替代常规组织病理学检查的风险和益处。